Nicholas Maskalenko

3PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 12, 2024
The FcγRIIIA (CD16) L48-H/R Polymorphism Enhances NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity by Promoting Serial Killing.

Nicholas A Maskalenko, Sam Zahroun, Oxana Tsygankova

|Mar 22, 2022
Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders.

Nicholas A Maskalenko, Dmitry Zhigarev, Kerry S Campbell

|Jun 03, 2020
The DISC1-Girdin complex - a missing link in signaling to the T cell cytoskeleton.

Nicholas Maskalenko, Shubhankar Nath, Adarsh Ramakrishnan

Pageof 1

Frequent Collaborators

2 joint publications

Kerry S Campbell

2 joint publications

Nadia Anikeeva

2 joint publications

Yuri Sykulev

1 joint publications

Dmitry Zhigarev